Showing results (131-140 of 232) with videos related to

Sort By:
Pageof 24
Ebiomedicine|May 27, 2020
CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinomaKatrin Kleinmanns, Katharina Bischof, Shamundeeswari Anandan, et al.
Plos One|June 22, 2012
Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertensionCornelia Schuster, Hans P Eikesdal, Hanne Puntervoll, et al.
International Journal of Oncology|November 18, 2004
Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expressionHelga B Salvesen, Ingunn Stefansson, Ellen I Kretzschmar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumorsKarin Collett, Ingunn M Stefansson, Johan Eide, et al.
NPJ Breast Cancer|April 9, 2026
Stromal-based proteome data improve stratification of hormone receptor-positive breast cancerKenneth Finne, Silje Kjølle, Magdalena Ríos Romero, et al.
Scientific Reports|February 15, 2025
Distinct clinicopathological features and treatment differences in breast cancer patients of young ageRasmus O C Humlevik, Amalie A Svanøe, Turid Aas, et al.
International Journal of Cancer|February 22, 2005
Low frequency of BRAF and CDKN2A mutations in endometrial cancerHelga B Salvesen, Rajiv Kumar, Ingunn Stefansson, et al.
Radiology|May 11, 2021
Interval and Subsequent Round Breast Cancer in a Randomized Controlled Trial Comparing Digital Breast Tomosynthesis and Digital Mammography ScreeningSolveig Hofvind, Nataliia Moshina, Åsne S Holen, et al.
The American Journal of Pathology|February 2, 2011
Gene expression patterns related to vascular invasion and aggressive features in endometrial cancerMonica Mannelqvist, Ingunn M Stefansson, Geir Bredholt, et al.
BMC Cancer|July 26, 2007
Use of immunohistochemical markers can refine prognosis in triple negative breast cancerMarc Tischkowitz, Jean-Sébastien Brunet, Louis R Bégin, et al.
Pageof 24